Drug interaction study reveals how itraconazole alters lurbinectedin levels
NCT ID NCT05063318
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 30 times
Summary
This study looked at how the antifungal drug itraconazole changes the way the body processes the cancer drug lurbinectedin. Fourteen adults with advanced solid tumors that had no standard treatment took part. The goal was to measure drug levels in the blood to understand the interaction, not to treat the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fundacion Jimenez Diaz
Madrid, 28040, Spain
-
Hospital HM Sanchinarro
Madrid, 28050, Spain
Conditions
Explore the condition pages connected to this study.